Calliditas Therapeutics Ab (0A5R)
LSE
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current 0A5R market cap is 0. The company's latest EPS is SEK and P/E is N/A.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 184.83M | 874k | 229.35M | 802.88M | 1.21B |
| Operating Income | -27.88M | -382.22M | -522.84M | -414.81M | -409.42M |
| Net Income | -32.58M | -433.49M | -500.29M | -412.27M | -466.19M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 845.2M | 1.51B | 1.46B | 1.95B | 1.86B |
| Total Liabilities | 57.13M | 250.15M | 451.63M | 1.19B | 1.52B |
| Total Equity | 788.07M | 1.26B | 1.01B | 766.26M | 334.81M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | -71.01M | -309.18M | -461.59M | -311.35M | -434.66M |
| Investing | -18.07M | -172.61M | -24.34M | -5.14M | -13.75M |
| Financing | 198.84M | 768.56M | 435.16M | 575.99M | 199.65M |
| Market Cap | 0 |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 59.58M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Calliditas Therapeutics Ab |
| Address |
kungsbron 1, c8 stockholm SE-111 22 |
| Website | https://www.calliditas.se |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
